Treatment of anal fissura with isorsorbide dinitrate or Botuline toxine A gives approximately comparative outcomes. Because of intensive treatment with isosorbide dintrate creme, patient treated with Botuline toxine A wil be more satisfactioned.…
ID
Bron
Verkorte titel
Ondersteuning
Hoofdweg Oostzijde 620
2132 MJ Hoofddorp nederland
tel: 023-5541600
fax: 0235541609
www.IPSEN.NL@IPSEN.com
www.ipsen.com
Hoofdweg Oostzijde 620
2132 MJ Hoofddorp nederland
tel: 023-5541600
fax: 0235541609
www.IPSEN.NL@IPSEN.com
www.ipsen.com
Onderzoeksproduct en/of interventie
Uitkomstmaten
Primaire uitkomstmaten
1. Patient satisfaction after 6 weeks;<br>
2. Visual Analoge Score on week 0,6 and 12.
Achtergrond van het onderzoek
Prospective randomised multicentre trial of satisfaction of treatment of anal fissure with isosorbide dinitrate or botuline toxin A injections.
Doel van het onderzoek
Treatment of anal fissura with isorsorbide dinitrate or Botuline toxine A gives approximately comparative outcomes. Because of intensive treatment with isosorbide dintrate creme, patient treated with Botuline toxine A wil be more satisfactioned. After six weeks treatment with Botuline toxine A, the patient satisfaction wil be significant more than patients treated with isosorbide dinitrate.
Onderzoeksopzet
N/A
Onderzoeksproduct en/of interventie
ISDN1% Creme versus Botuline Toxine A
Duration 12 weeks.
ISDN creme application every 4 ours for 12 weeks.
Or Botuline Toxine A injection at week 0 and if neccesary at week 6 again
Botuline Toxine A Dysport fabrikant Ipsen.
Publiek
Department of Surgery,
P.O. Box 9243
W.F. Tets
Jan Tooropstraat 164
Amsterdam 1006 AE
The Netherlands
w.vantets@slaz.nl
Wetenschappelijk
Department of Surgery,
P.O. Box 9243
W.F. Tets
Jan Tooropstraat 164
Amsterdam 1006 AE
The Netherlands
w.vantets@slaz.nl
Belangrijkste voorwaarden om deel te mogen nemen (Inclusiecriteria)
1. Diagnosed anal fissura with complaints;
2. Complaints longer than 2 months;
3. Age 21-60 year;
4. Speaking dutch;
5. Will-competent;
6. Informed consent.
Belangrijkste redenen om niet deel te kunnen nemen (Exclusiecriteria)
1. Pregnancy, lactation;
2. Muscle-sicknesses such as myasthenia gravis;
3. Simultaneous use of medication interacting with neuromusculair transmission;
4. Fistulas;
5. Coagulation disorders or th use of anticoagulantia;
6. Anal surgery in the past;
7. Haemorrhoiden or inflammatory bowel sicknesses as a cause of anal fissure;
8. Major secundaire changes because of the anal fissure.
Opzet
Deelname
Opgevolgd door onderstaande (mogelijk meer actuele) registratie
Geen registraties gevonden.
Andere (mogelijk minder actuele) registraties in dit register
Geen registraties gevonden.
In overige registers
| Register | ID |
|---|---|
| NTR-new | NL402 |
| NTR-old | NTR441 |
| Ander register | : 2004/149 |
| ISRCTN | ISRCTN85367943 |